Nox 4 regulation of vascular smooth muscle cell differentiation marker gene expression.
Hamid Deliri,C. McNamara
DOI: https://doi.org/10.1161/01.ATV.0000254154.43871.50
Abstract:Vascular smooth muscle cells (VSMCs) undergo phenotypic switching in response to vascular injury. A hallmark feature of VSMC phenotypic switching is altered expression of VSMC-selective genes that define the contractile phenotype, including SMα-actin, SMC myosin heavy chain (SM-MHC), Calponin, SM22α, and H-caldesmon.1 Although expression of no single marker is specific for SMC lineage, SM-MHC appears to be the most specific marker to date.2,3 After acute vascular injury of an intact blood vessel, the expression of SMC differentiation markers are transiently decreased 7 days after vascular injury, when VSMCs are proliferating and migrating into the neointima.4,5 Expression of SMC marker proteins is largely regulated at the gene transcription level in vitro and in vivo.4,6 Transcriptional regulation of many of these contractile proteins involves the transcription factor serum response factor (SRF), which binds CArG cis regulatory elements. Recent studies have shown that myocardin and myocardin-related factors (MRTFA, MRTFB or MKL1, MKL2) function as SRF coactivators and are required for SRF:CArG-dependent regulation of VSMC-selective genes. SRF activity itself is also regulated by posttranscriptional mechanisms such as phosphorylation and alternative splicing.6
See page 42
Reactive oxygen species (ROS), like superoxide anions and hydrogen peroxide, have been implicated in a variety of processes involved in vascular lesion formation such as proliferation, differentiation, and apoptosis.7,8 Classically described as microcidal byproducts of oxidative metabolism, they also function as intracellular second messengers in minute concentrations that can activate cellular signaling cascades. In their role as intracellular second messengers, ROS can activate βγ-subunit of G proteins, regulate kinase pathways such as Src, Ras, JAK2, Pyk2, PI3K, and MAPK, inhibit protein phosphatases, modify the activity of phospholipases, alter intracellular cation concentrations by stimulating Ca2+ and K+ channels, and regulate expression and function of transcription factors such as NFκB, activator protein-1, and hypoxia-inducible …